Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE2SPOND rationale and study design

Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE2SPOND rationale and study design

Stephen I Rennard,1,2 Fernando J Martinez,3,4 Klaus F Rabe,5–7 Sanjay Sethi,8 Emilio Pizzichini,9 Andrew McIvor,10 Shahid Siddiqui,11 Antonio Anzueto,12 Haiyuan Zhu13 1Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, USA; 2AstraZeneca, Cambridge, UK; 3Joa...

Full description

Bibliographic Details
Main Authors: Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H
Format: Article
Language:English
Published: Dove Medical Press 2016-08-01
Series:International Journal of COPD
Subjects:
chronic obstructive pulmonary disease
COPD
roflumilast
LABA
ICS
Online Access:https://www.dovepress.com/effects-of-roflumilast-in-copd-patients-receiving-inhaled-corticostero-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/effects-of-roflumilast-in-copd-patients-receiving-inhaled-corticostero-peer-reviewed-article-COPD

Similar Items